2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
2
Head & Neck
1
Conditions
Neuralgia
1
Head and Neck Neoplasms
1
Breast Neoplasms
1
Breast Cancer Patient
1
Agnosia
1
Interventions
pembrolizumab
1265
Specimen Handling
926
Magnetic Resonance Spectroscopy
830
Carboplatin
823
Cyclophosphamide
800
Cisplatin
723
Nivolumab
669
Paclitaxel
627
Radiotherapy
611
Gemcitabine
573
Biopsy
557
Bevacizumab
478
Dexamethasone
438
fludarabine
407
Docetaxel
380
venetoclax
368
Oxaliplatin
364
Capecitabine
358
Fluorouracil
355
atezolizumab
350
durvalumab
332
Rituximab
330
Drug Therapy
326
Doxorubicin
316
Radiosurgery
315
Standard of Care
309
Blood Specimen Collection
308
Pemetrexed
305
Ipilimumab
299
Radiation
286
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Capsaicin
×
1 year
×
Clear all
NCT03794388
2026-05-05
CAPTRANE
Institut Cancerologie de l'Ouest
Phase 3
Completed
140 enrolled
6 charts
NCT04704453
2026-04-14
TEC-ORL
Institut Claudius Regaud
Phase 2
Completed
13 enrolled
NCT06807164
2026-03-27
SerCaBot
Centre Oscar Lambret
Phase 2
Recruiting
123 enrolled